Page 21 - 第22屆新創事業獎得獎專輯
P. 21
科技產業組 Tech Industry Category
as "Stem Cell 4.0". Among all types of stem Future Prospects
cells, AFSCs are the most appropriate ones
for the development of various medical U-Neuron is committed to using AFSCs
indications and scale-up production to meet technology as the core competence,
the requirements of regenerative therapies. focusing on neurological, inflammatory,
AFSCs, with endodermal, mesodermal and and degenerative diseases, developing
ectodermal differentiation abilities, hold regenerative medicine to improve patients'
significant neural differentiation potentials quality of life. U-Neuron continues to
to regenerate or repair nerve cells and treat develop second-generation AFSCs isolation
nerve-related diseases. Based on the unique technology and new preparations, such as
characteristics of AFSCs, U-Neuron enters the cell sheets or cell microspheres and other
field of neurological diseases. In addition, different types of cell preparations, for deeply
U-Neuron has developed own unique engagement in the fields of neurological,
technology to develop exosome products inflammatory, and degenerative diseases to
from conditioned medium of AFSCs culture. accelerate the development of new drugs.
Inheriting the characteristics of stem cells, the This will effectively translate the regenerative
technology is suitable for the development technology into clinically applicable drugs.
of indications related to anti-inflammation By applying patents and product portfolios,
and promoting tissue repair. Because the U-Neuron would perform the global licensing
exosome product does not contain cells, the deals for return while accumulating drug
barrier of transportation and storage of the development achievements, and become
product would be low, and it can become an a benchmark company in the regenerative
alternative to cell-free regenerative medicine. cell therapy area. In terms of cosmetic &
As for cosmetics and healthcare products, healthcare consumer products, U-Neuron
the deer amniotic fluid stem cell derivative pursues the development of active ingredients
developed by U-Neuron has obtained INCI for consumer healthcare products and is
certification, the International Nomenclature committed to providing key ingredients
of Cosmetic Ingredient, and has great with decent efficacy and safety. U-Neuron
potential for product development at the promotes local healthcare market while
global level. cooperates with global business partners to
expand and attract more international ODM/
OEM customers, therefore expanding products
to global markets.
20
